Radiother Oncol 2013 Nov
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
Related Questions
Addition of Cetuximab with re-irradiation SBRT in H&N Ca was mentioned previously:
https://www.themednet.org/question/1936
https://www.themednet...
New answer by Radiation Oncologist at University of Florida (May 11, 2021)
I don’t use SBRT to re-irradiate head and neck cancer. Out of field failure is very likely.